Resistance to flow through tissue-isolated transplanted rat tumours located in two different sites. by Sensky, P. L. et al.
Br. J. Cancer (1993), 67, 1337-1341 1993
Resistance to flow through tissue-isolated transplanted rat tumours
located in two different sites
P.L. Senskyl2, V.E. Prisel, G.M. Tozer', K.M. Shaffi' & D.G. Hirst'
CRC Gray Laboratory, PO Box 100, Mount Vernon Hospital, Northwood, Middlesex HA6 2JR, UK.
Summary The perfusion characteristics of the P22 carcinosarcoma were investigated in tissue-isolated tumour
preparations in the ovarian and inguinal fat pads of BD9 rats. Tumours were perfused with a physiological
buffer of known viscosity and changes in perfusion pressure were recorded at different perfusion rates in an ex
vivo system. At perfusion pressures exceeding 30-40 mmHg tumour flow rate was directly proportional to the
perfusion pressure in all tumours, indicating a constant resistance to flow. An apparent positive pressure
difference across the tumour vasculature of 20-30 mmHg occurred under conditions of zero flow in either site.
At low perfusion pressures, the flow resistance increased sharply due to increases in the geometric resistance of
the tumours. These findings are in accord with previously published data. Geometric resistance increased with
tumour volume in both sites and was approximately five times greater in the inguinal tumours than it was in
the ovarian tumours, on a weight to weight basis. The dependence of tumour geometric resistance on
perfusion pressure differs from the situation in normal tissues and may provide a means of manipulating the
tumour microcirculation to the exclusion of the systemic blood supply. The dependence of geometric resistance
on tumour site may partly explain why tumours located in different sites respond differently to various forms
of therapy.
The potential importance of differentially modifying tumour
perfusion as a means of enhancing some forms of cancer
therapy has been recently reviewed (Jirtle, 1988; Hirst &
Wood, 1989; Jain, 1990). The delivery of oxygen and other
radiosensitisers is enhanced when tumour perfusion is in-
creased, as is the delivery of chemotherapeutic agents to the
tumour, whilst reducing tumour blood flow has been shown
to have value in the response of tumours to hyperthermia.
The identification of those factors which may be modified to
produce a preferential change in tumour perfusion could
have important implications for therapy.
Tumour perfusion rate, q, is dependent on the pressure
gradient across the tumour vascular bed, AP, and on the
resistance to flow, FR, imposed by the geometric resistance of
the vasculature, z, and the viscosity of the perfusing fluid, ij:
AP AP
q= =
FR riz
Ex vivo perfusion of tissue-isolated tumours supplied by a
single artery and drained by a single vein permits determina-
tion of both FR and z, if i is known, of a tumour over a
range of perfusion pressures (Sevick & Jain, 1989a,b). In the
rat, there are two suitable sites in which tissue-isolated
tumours can be grown, the ovarian and inguinal fat pads
(Gullino & Grantham, 1961; Grantham et al., 1973).
One of the many problems encountered in trying to predict
the outcome of various forms of cancer therapy is the
variability of the response of tumours of the same type
located in different sites to physiological manipulations (Hirst
et al., 1991). Using the two isolated tumour models, the
opportunity exists to characterise the physiological para-
meters governing perfusion in each site and this may provide
an indication as to the mechanism behind the site
dependency of tumour response to treatment.
Materials and methods
Animals and tumour
A transplanted rat carcinosarcoma, designated P22, was used
for these experiments. This tumour arose in the treated site
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of a male BD9 rat following irradiation of the spinal cord in
the cervical region. The tumour was serially transplanted
subcutaneously in BD9 rats up to the eighth passage away
from the primary tumour. Animals were fed a standard
laboratory diet, given ad libitum.
Preparation oftissue-isolated tumours
Rats were anaesthetised with a mixture of 5 mgkg-'
midazolam hydrochloride (Hypnovel, Roche Products Ltd.),
10mg kg-' fluanisone and 315jig kg-' fentanyl citrate (Hyp-
norm, Janssen Pharmaceuticals Ltd.), i.p.
Ovarian fat pad Ovarian-isolated tumours were implanted
using the technique established by Gullino & Grantham
(1961), using parafilm as the enclosing material.
Inguinal fat pad A 1-2 cm incision was made in the skin
overlying the inner right thigh of male rats. The fat pad
supplied by the epigastric artery was identified and cut free
so that no contralateral supply was possible. The epigastric
vessels were carefully cleared of any fat and connective tissue
between the fat pad and the femoral vessels. The inguinal fat
pad was cut so that a piece of fat ; 3-5 mm3 was left
attached to the vascular pedicle. Two I mm3 tumour
fragments were placed in the fat pad which was subsequently
enclosed in a specially designed silicone chamber. The
chambers were prepared by applying a mixture of 10% Silas-
tic Curing Agent (w/w) and Silastic Medical Grade Elas-
tomer (Dow Corning Corporation) in a thin layer over
suitable moulds and heating at 140°C for approximately
5 min. The slit required to remove the chamber from the
mould enabled the inguinal fat pad to be positioned inside
the chamber. The slit was sealed with surgical adhesive
(Histoacryl, Cyanamid UK Ltd.). This form of enclosing
material was found to be necessary in this site due to the
tissue reaction which occurred using parafilm. Furthermore,
in contrast to its use in the ovarian site, the parafilm tended
to disintegrate when placed in the inguinal site, rendering it
an ineffective isolating material. The chamber was carefully
positioned under the skin and anchored with suture to part
of the remaining inguinal fat to prevent twisting of the
pedicle. Penicillin was applied to the surgical field, and the
wound was closed. The flexibility of the silicone was such
that tumour growth was not restricted as tumours grew to fill
the chamber. Drainage holes cut in the chamber allowed fluid
resulting from leakage at the tumour periphery to escape.
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Post-operative care
Immediately following surgery, the teeth and claws of all rats
were clipped. This was found necessary to prevent the wound
from opening and was repeated 3 days after surgery.
Subcutaneous administration of a few millilitres of dextrose/
saline solution ensured rapid rehydration of the animals post-
operatively. The rats were then kept warm on a heating
blanket until partial consciousness was regained. They were
then caged separately and provided with soft diet for the first
week after surgery.
Exteriorisation ofisolated tumoursfor ex vivo perfusion
Perfusion experiments were carried out on tumours after a
3-4 week growth period. The rats were anaesthetised and
body temperature was maintained at 37°C by a thermo-
statically controlled heated pad. Having checked the viability
of the isolated tumours after the removal of the isolating
material, the carotid artery and jugular vein were catheter-
ised, permitting the continual monitoring of arterial blood
pressure (transducer model P23XL, Spectramed) and the i.v.
administration of further anaesthetic and 300 USP units
heparin immediately prior to catheterising the venous side of
the tumour vasculature. For tumours located in the ovarian
fat pad the aorta and left renal vein were catheterised and the
left kidney was excised, as described by Sevick & Jain
(1989a). For those located in the inguinal fat pad, catheters
were placed in the saphenous artery and the femoral vein.
Perfusion of Krebs-Henseleit (KH) buffer, pH 7.4 (Sigma
Chemical Co. Ltd.), containing 5% bovine serum albumin
(Sigma), 7 USP units ml-' sodium heparin (CP Phar-
maceuticals Ltd.) and 1.5 mM papaverine (Sigma) was
initiated immediately following the catheterisation of the
arterial side of the tumour, maintaining the arterial blood
pressure at normal values (t 100 ± 20 mmHg). The viscosity
of the buffer was 1.0 ± 0.1 cP (Cone & Plate Viscometer,
model LVDVIII, Brookfield Viscometers). The systemic sup-
ply to the tumour was then tied so that only perfusate
supplied the tumour, with the venous perfusate draining to
atmosphere. The animal was killed with a lethal dose of
200 mg ml-l sodium pentobarbitone (Euthatal, May & Baker
Ltd.) administered via the catheter in the jugular vein. The
catheterised isolated tumour was then placed in an en-
vironmentally controlled chamber, permitting experiments to
be performed.
Ex vivoperfusion
Continuous flow of perfusate to the tumour was maintained
via a peristaltic pump (model 202U/AA, Watson-Marlow) set
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initially at t25 ml h-' for the ovarian tumours or at
; 15 ml h-' for the inguinal tumours to produce arterio-
venous pressure differences of 60-80 mmHg. The perfusate
was passed through t 3 metres of thin-walled semi-
permeable silicone rubber tubing (i.d./o.d. 1.0/1.5 mm, Altec)
inside an oxygenator, kept at 37°C, into which a gas mixture
of95% 02 and 5% CO2 flowed at a rate of -21 min-'. This
raised perfusate 02 and CO2 tensions to 490 ± 11 mmHg and
36.3 ± 0.7 mmHg, respectively, ensuring adequate oxygena-
tion on entering the tumour artery (Corning 178 pH/Blood
Gas Analyzer, Corning Medical). Perfusate osmolality was
measured to be between 294-300 mOsm kg-' (Advanced
Micro-osmometer Model 3MO, Advanced Instruments Inc.).
Pressure readings were made over flow rates of 1-60 ml h-'
in the ovarian tumours and 1-30mlh-1 in the inguinal
tumours.
Results
Tumour viability ana size
Of 14 inguinal and 13 ovarian tumours perfused, subsequent
histological examination revealed significant regions of fatty
tissue or necrosis in four tumours in each site. These demon-
strated highly unstable perfusion characteristics and were
excluded from the analysis of the data obtained from viable
tumours.
Ten viable inguinal (0.995 ± 0.139 (s.e.m.) g; range 0.391-
1.681 g) and nine ovarian (2.186 ± 0.389 g; range 0.550-
4.085 g) isolated tumours were perfused with KH buffer. The
mean PO2 of the perfusate collected from the tumour vein
(pH 7.34 ± 0.01) was 297 ± 13.5 mmHg indicating that ade-
quate tumour oxygenation had been maintained throughout
the course of the perfusion.
Dependence ofthe arteriovenous pressure difference on tumour
perfusion rate
In both inguinal and ovarian isolated tumours the A-V
pressure drop across the vascular bed was directly propor-
tional to perfusion rate at pressures greater than t40 mmHg
(Figure 1). By extrapolating the linear portion of the AP-q
plots, an apparent pressure associated with a state of no flow
through the tumour was determined. This pressure, APO, was
calculated as 20.79 ± 2.43 mmHg in the inguinal tumours
and 24.69 ± 3.93 mmHg in the ovarian tumours, providing
no evidence of any statistically significant difference between
the two tumour sites (Student's unpaired t test).
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Figure 1 Pressure-flow characteristics of ovarian and inguinal-isolated tumours. All the curves demonstrate a non-zero intercept
on the pressure axis, APO. The symbols represent the data obtained for individual tumours ofdifferent sizes, decreasing in the order
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Flow resistance ofisolated tumours
The resistance to flow at any given pressure in the two
tissue-isolated tumours was calculated and plotted as a func-
tion of perfusion pressure (Figure 2). Above perfusion pres-
sures of ; 40 mmHg FR remained relatively constant. Below
this threshold, large increases in FR occurred as the pressure
tended towards A\PO. Table I indicates the FR at perfusion
pressures of 25, 60 and 100 mmHg for each tumour site. In
both sites the FR at 25 mmHg was significantly greater than
it was at 60 mmHg (P<0.05 and P<0.0l for the inguinal
and ovarian tumours, respectively). There was no evidence
that the FR measured at 60 mmHg and that measured at
100 mmHg differed significantly. Over the normal perfusion
pressure range the FR of inguinal tumours was consistently
greater than that of the ovarian-isolated tumours (P<0.05).
The FR above the apparent closing pressure of each
tumour, FRO, can be calculated from the gradient of the AP-q
plots. Using this method, the FRo of inguinal tumours was
3.575 ± 0.569 mmHg.h.g cm-3. This was significantly higher
than the FRo of the ovarian tumours (1.595 ± 0.319
mmHg.h.g cm-3) (P<0.01).
Geometric resistance to bloodflow
The geometric resistance, z, for each tumour can be cal-
culated since the viscosity of the perfusing buffer is known.
Since z = FR/, the relationship between perfusion pressure
and z is similar to the relationship between pressure and FR.
The z0 of inguinal tumours (1.911 ± 0.305) x 109 g cm 3,
differs significantly from the z0 of ovarian tumours ((0.853 +
0.171) x 109gcm-3) (P<0.01).
Correlation offlow rate andgeometric resistance with weight
The rate of perfusion required to maintain a constant per-
fusion pressure of 60 mmHg (q60) decreases significantly with
increasing tumour size in both ovarian (r2 = 0.72) and
inguinal (r2 = 0.81) sites, with the effect being more marked
in the inguinal tumours (Figure 3a).
Tumour mass, w, also correlates significantly with the
resistance to flow imposed by the vascular geometry of the
tumours. Figure 3b shows the linear relationship between w
and z0 producing the relationships:
Ovarian: z0 = (3.93 ± 0.28) x 108 w (r2 = 0.84)
Inguinal: zo=(1.94 ± 0.11) x 109w (r2= 0.86)
Thus, at any given tumour size, the 109 geometric resis-
tance will be ; 5 times greater if the tumour is located in the
inguinal fat pad, a difference of statistical significance
(P<0.001).
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Table I Flow resistance ofinguinal and ovarian isolated tumours at
perfusion pressures of 25, 60 and 100 mmHg
(mmHghgcm-3)
Tumour n FR25 FR60 FR,OO
Inguinal 10 13.473 ± 3.136a 5.963 ± 1.153 4.586 ± 0.774
Ovarian 9 8.842 2.331a 2.737 0.552 2.076 0.396
a'n I inguinal and 2 ovarian tumours, perfusion was not undertaken
at pressures below the departure from linearity, i.e. t40 mmHg.
Extrapolation ofthelinearportionofthe AP-FRplotsofthese tumours
would distort the data.
Discussion
The linear dependence of flow rate on perfusion pressure has
been previously demonstrated in a variety of perfused
isolated tissue systems (Whittaker & Winton, 1933; Hint,
1964; Sutera et al., 1988; Sevick & Jain, 1989a). A small
apparent pressure associated with conditions of zero flow,
AlPO, has been noted in several normal tissues perfused with
physiological Ringer's solutions. Its magnitude (<8 mmHg)
suggests that it can be attributed solely to tissue oedema. In
our isolated solid tumours, however, A/PO deviates sig-
nificantly from zero, averaging 20.79 ± 2.43 mmHg and
24.69 ± 3.93 mmHg in the inguinal and ovarian P22 car-
cinosarcomas, respectively. Similar values of APO have been
reported in the isolated R3230AC mammary carcinoma
grown in the ovarian fat pad (Sevick & Jain, 1989a). The
magnitude of this value suggests that it cannot be attributed
to tissue oedema alone, which is greatly reduced by the
inclusion of albumin in the perfusate used in the present
experiments. Consequently, the tumour vasculature must
exhibit an increased resistance to flow as the perfusion pres-
sure is reduced towards APO. This characteristic of the
tumour vasculature, absent in normal tissues, theoretically
provides a means of manipulating the tumour microcircula-
tion without affecting the systemic circulation, although the
hypotension that would need to be induced to initiate the
increase in FR is not clinically feasible.
The increase in FR at low perfusion pressures must arise
from an elevation of the geometric resistance of the tumour,
since the viscosity of the KH buffer, a fluid with Newtonian
properties, is constant. The magnitude of the increase in
geometric resistance (Figure 2) implies that there must be
some compression of the resistance vessels (z a 1/r4), possibly
resulting in vascular collapse. This will occur if the pressure
inside the vessels is unable to overcome the combination of
extravascular pressures exerted by the fluid in the inter-
stitium, i.e. the interstitial fluid pressure (IFP), and the pres-
sure resulting from the proliferation of cancer cells within a
30-
25-
20-
157
10-
5- n.
100
Inguinal tumours
V. ' I ' t 1 ' I '
0 ' ' . I ' ' ..I v'
I I
0 20 40 60 60. 100 120 140 160
Perfusion pre'sure (mmHg)
Figure 2 Variation in flow resistance over a range of perfusion pressures in ovarian and inguinal tumours of different sizes. The
symbols represent the same tumours in Figure 1.
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Figure 3 a, Exponential fit between tumour weight and perfusion rate at 60 mmHg (r2 = 0.904 and 0.733 for inguinal and ovarian
tumours, respectively) and b, the linear relationship between tumour size and the geometric resistance to flow above the apparent
closing pressure, zo (r2 = 0.927 and 0.917), calculated from the gradient of the q-AP and the viscosity of the perfusate (O inguinal
tumours; 0 ovarian tumours).
confined and relatively non-compliant space (Pa). At low
perfusion pressures these extravascular pressures could be
greater than the intravascular pressure causing vascular col-
lapse. A recent study using the isolated R3230AC tumour
infers that the interstitial hypertension, commonly measured
in experimental and human tumours (Boucher et al., 1990;
Boucher et al., 1991; Roh et al., 1991; Gutmann et al., 1992)
is driven by an increase in microvascular pressure arising
from the high permeability of the tumour vasculature and the
absence of a functional lymphatic circulation (Boucher &
Jain, 1992). This suggests that tumour IFP cannot exceed the
intravascular pressure so that increases in vascular resistance
must result from P, Without information regarding the tem-
poral changes in IFP and the microvascular pressure which
may occur following induced changes in the perfusion pres-
sure, a state whereby the IFP is temporarily greater than the
microvascular pressure cannot be excluded.
The dependence of tumour perfusion rate and flow resis-
tance on tumour volume has been previously demonstrated
in several tumour types (Cataland et al., 1962; Vaupel, 1975;
Song et al., 1980; Sevick & Jain, 1989a; Tozer et al., 1990).
Ex vivo perfusion of inguinal and ovarian isolated tumours
shows that this dependence applies at physiological perfusion
pressures. The increased resistance of larger tumours is prob-
ably a function of the extravascular pressures. Tumour IFP is
significantly greater in the centre of the growing mass than it
is at the periphery, with a marked decrease occurring at
depths of <0.8-1.0 mm (Boucher et al., 1990). Conse-
quently, in smaller tumours the proportion of vessels suscep-
tible to collapse due to raised IFP is lower than it is in larger
tumours. Over the range of tumours included in this study,
calculation of the percentage of the central volume of the
tumour (excluding the outer 1 mm) relative to the tumour as
a whole produces values between
' 50% and ; 73% with
increasing tumour size, assuming a tissue density of 1 g cm-3.
Reports that the radius of vessels in viable regions of
tumours increases with increasing tumour volume imply that
z may actually decline at the periphery of solid tumours
(Vogel, 1965). However, the overall effect is an increase in
the geometric resistance of larger tumours, since the in-
creased resistance in the central areas of the tumour
outweighs any reduced peripheral effects. This is augmented
by the increased PC arising from cellular proliferation.
Whilst the behaviour of isolated tumours of the same
tumour type implanted in two different sites bears a notable
similarity with respect to the dependence of flow rate and
flow resistance on both perfusion pressure and tumour size,
tumours of equivalent weights displayed marked differences
in their resistance to flow, dependent on their site of growth.
The geometric resistance of the isolated P22 carcinosar-
coma was approximately five times greater in the inguinal site
than in the ovarian site. This difference must be dependent
on the actual tumour mass itself and not on the resistance
imposed by the feeding artery. Under the conditions em-
ployed in this study, the inclusion of papaverine in the
perfusate produces maximal vasodilation of the host vessels.
Furthermore, the relative dimensions of the epigastric artery
and the ovarian artery would tend to favour a higher resis-
tance in the ovarian vessel. Severing the tumour from its
feeding artery in either site abolishes all measurable resis-
tance in the system, so arterial resistance must be negligible.
The possibility that the enclosing material may affect z
must also be considered. The difficulties experienced when
using parafilm in the inguinal site, i.e. the formation of
granular tissue and constriction, or twisting, of the vascular
pedicle, enforced the use of an alternative isolating material
which could be held in position. All inguinal tumours were
taken for experiments at a stage when the silicone chamber
was not completely filled. Drainage holes in the silicone
chamber ensured that fluid leaking from the tumour
periphery did not exert external pressure on the growing
tumour. Tumours growing in the inguinal site may be subject
to changes in external pressures during normal animal
movements. Silicone was considered unsuitable for use in the
ovarian site as the lack of a suitable anchorage point results
in the twisting of the tumour vascular pedicle, thereby
occluding the blood supply to the tumour. Tumours in the
ovarian site were allowed to grow to larger sizes in the
inguinal site because the parafilm was more flexible and the
area of growth less restricted.
Differences in z may also arise if the functional cross-
sectional area and the functional vascular volume of the two
tumours differ. Histological examination of unperfused
tumours reveals little difference in the vascular concentration
in either site. Unfortunately, this neither gives spatial nor
temporal information on vascular function during perfusion.
However, there does appear to be a difference in functional
vascular volume. The clearance of red blood cells from the
inguinal tumours was found to occur within 3 min of the
onset of perfusion at perfusion rates of 11.75 ml h-', whilst
clearance from the ovarian tumours generally took longer at
a faster rate of perfusion, i.e. up to 10min at 22.5 ml h-.
This implies that either blood is rapidly shunted from the
arterial to venous side in the inguinal site or that the func-
tional vascular volume is greater in the ovarian tumour. If
the second of these possibilities is true, this may be sufficient
to account for the 5-fold difference in geometric resistance
observed.
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Information on IFP and PC in these tumours may enable a
more complete picture to be drawn. If the IFP is lower in the
ovarian fat pad tumour, then vascular compression and the
geometric resistance will be considerably reduced. The con-
straints of the site of tumour growth suggest that PC could be
greater in the inguinal site. Without further studies, however,
this remains speculative.
The dependence of FR on tumour location may relate to
the response of tumours located in different sites to various
haemodynamic and vasoactive alterations. Anaemia has been
shown to significantly reduce the relative perfusion of CaNT
tumours implanted intradermally on the back of CBA mice
whilst having little effect on the perfusion rate of tumours
implanted in the abdominal fat pad (Sensky et al., 1993).
This may be due to a lower FR in the abdominal site arising
from its less constrained growth site. Similarly, the vaso-
dilators hydralazine and 5-HT, and the vasoconstrictor
angiotensin II produce different effects on the perfusion of
tumours which depend on their location (Hirst et al., 1991).
The use of ex vivo isolated tumours growing in two sites with
different FR's enables further investigations to establish
whether FR is an important determinant of response to such
agents.
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